Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Naloxone Distribution to Patients in Emergency Department Raises Controversy

By Catherine A. Marco, MD, FACEP; John E. Jesus, MD, FACEP; Joel M. Geiderman, MD, FACEP; and Eileen F. Baker, MD, FACEP | on June 15, 2016 | 1 Comment
ED Critical Care New Spin Opinion
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Naloxone Distribution to Patients in Emergency Department Raises Controversy
You Might Also Like
  • Naloxone Distribution Strategies Needed in Emergency Departments
  • Naloxone to Reduce Opiate Overdose Deaths Raises Cost, Liability, and Safety Concerns
  • Overdose Antidote Naloxone Hydrochloride Available in California Pharmacies
Explore This Issue
ACEP Now: Vol 35 – No 06 – June 2016

Pages: 1 2 | Single Page

Topics: AddictionCritical CareDrug AbuseEmergency DepartmentEmergency PhysicianHeroinMorbidityMortalityNaloxoneOpioidPatient CarePractice Management

Related

  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Florida Emergency Department Adds Medication-Dispensing Kiosk

    November 7, 2025 - 1 Comment
  • Q&A with ACEP President L. Anthony Cirillo

    November 5, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

One Response to “Naloxone Distribution to Patients in Emergency Department Raises Controversy”

  1. February 2, 2017

    Stuart Etengoff DO FACEP Reply

    The reference for the quote
    “While naloxone…”

    Agree with rest of article, however to raise the “possibility” of A=B, is the same as saying the availability of aspirin/AED decrease pts eating healthy.
    This is time dependant POC life saving treatment.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603